Factors Influencing Clinicians' Choice of Adjuvant S-1 versus Capecitabine plus Oxaliplatin after Curative Gastrectomy in Patients with Gastric Cancer

Factors Influencing Clinicians' Choice of Adjuvant S-1 versus Capecitabine plus Oxaliplatin after Curative Gastrectomy in Patients with Gastric Cancer

Purpose: Two recent randomized, phase III trials in Asia (ACTS-GC and CLASSIC) documented the survival benefit of postoperative chemotherapy after D2 lymph node dissection in patients with gastric cancer. We sought to determine what factors influenced clinicians' choices of either S-1 or capeci...

Full description

Bibliographic Details
Main Authors: Lee, Ha Yeon, Hwang, In Gyu, Park, Song-Ee, Kim, Moon Jin, Park, Se Hoon, Kang, Jung Hun, Kim, Young Saing, Oh, Sung Yong, Won, Young-Woong, Lee, Soon Il, Ji, Jun Ho, Chi, Kyong-Choun
Format: Online
Language:English
Published: Ivyspring International Publisher 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039392/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039392/

Similar Items